Segall Bryant & Hamill LLC Invests $3.41 Million in Kenvue Inc. $KVUE

Segall Bryant & Hamill LLC purchased a new stake in Kenvue Inc. (NYSE:KVUE) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 193,367 shares of the company’s stock, valued at approximately $3,413,000.

A number of other hedge funds and other institutional investors have also modified their holdings of KVUE. Montag A & Associates Inc. raised its holdings in Kenvue by 6.3% during the 1st quarter. Montag A & Associates Inc. now owns 10,156 shares of the company’s stock worth $175,000 after buying an additional 600 shares during the period. Cornerstone Wealth Group LLC lifted its stake in Kenvue by 5.9% during the first quarter. Cornerstone Wealth Group LLC now owns 10,810 shares of the company’s stock valued at $187,000 after buying an additional 606 shares in the last quarter. Physician Wealth Advisors Inc. boosted its holdings in shares of Kenvue by 67.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares during the period. Mill Creek Capital Advisors LLC boosted its holdings in shares of Kenvue by 0.6% in the fourth quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company’s stock worth $2,143,000 after buying an additional 701 shares during the period. Finally, B & T Capital Management DBA Alpha Capital Management boosted its holdings in shares of Kenvue by 0.3% in the fourth quarter. B & T Capital Management DBA Alpha Capital Management now owns 234,664 shares of the company’s stock worth $4,048,000 after buying an additional 712 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on KVUE. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a report on Sunday, July 12th. Barclays raised their price objective on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 21st. UBS Group lifted their price objective on shares of Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, July 16th. Zacks Research downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Finally, Citigroup decreased their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $19.58.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $18.98 on Tuesday. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.28. The business has a fifty day simple moving average of $18.62 and a 200 day simple moving average of $18.03. The firm has a market cap of $36.45 billion, a price-to-earnings ratio of 22.34, a P/E/G ratio of 1.46 and a beta of 0.47.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. During the same quarter last year, the firm earned $0.24 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. As a group, sell-side analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be paid a dividend of $0.21 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue’s dividend payout ratio (DPR) is 97.65%.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.59% of the stock is currently owned by corporate insiders.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.